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Genome-wide association studies (GWAS) have successfully identiﬁed a large number of genetic variants
associated with complex traits, but these only explain a small proportion of the total heritability. It has
been recently proposed that rare variants can create ‘synthetic association’ signals in GWAS, by occurring
more often in association with one of the alleles of a common tag single nucleotide polymorphism. While
the ultimate evaluation of this hypothesis will require the completion of large-scale sequencing studies, it
is informative to place it in the broader context of what is known about the genetic architecture of complex
disease. In this review, we draw from empirical and theoretical data to summarize evidence showing that
synthetic associations do not underlie many reported GWAS associations.
GENOME-WIDE ASSOCIATION STUDIES AND
‘THE MISSING HERITABILITY’
Numerous common human diseases and phenotypic traits are
believed to arise from a combination of genetic and environ-
mental factors. The unravelling of the genetic predisposition
to complex traits is a major challenge, and it could lead to
better prevention, diagnosis and treatment of disease.
Recently, advances in genotyping technologies, reduction in
genotyping costs and the availability of data regarding
genome-wide sequence variation through the International
HapMap Project and 1000 genomes project have made
genome-wide association studies (GWAS) possible. GWAS
have emerged as a powerful tool for identifying genetic var-
iants associated with complex traits. In the past few years,
more than 500 loci have been found to be associated with
human common diseases and traits (1). GWAS have proven
to be much more successful than linkage studies, which
were underpowered to detect variants of modest effect (2),
and candidate gene studies, which are non-systematic and
biased due to our limited knowledge of the biological path-
ways implicated in disease pathogenesis (3).
GWAS are based on the common disease–common variant
(CDCV) hypothesis (4), which states that relatively common
genetic variants (MAF . 5%) of relatively low penetrance are
important contributors to the genetic susceptibility to common
diseases. Well-powered GWAS, which capture a substantial
majorityofcommonvariationinthegenome,havebeennowcon-
ducted for many common diseases. However, for the majority of
these diseases, common variants explain only a small proportion
ofheritability(5),duetosmallindividualeffect sizes.Ithasbeen
estimated that only 13% of all identiﬁed susceptibility loci have
odds ratios (OR) above 2, and only 1% have OR above 10 (6).
For example, if we consider a total estimated sibling recurrence
risk ratio (ls) of 5–10 for rheumatoid arthritis (RA) (7), 15 for
type 1 diabetes (T1D) (8), 17–35 for Crohn’s disease (CD) (9)
and 3 for type 2 diabetes (T2D) (10), their established suscepti-
bility loci would contribute  33–47%, 55.6%, 10–12.6% and
11.9% of the total heritability, respectively (Table 1).
POSSIBLE CONTRIBUTORS TO THE
UNEXPLAINED HERITABILITY
Explaining this ‘missing heritability’ of complex diseases
(11–13) is an area of active research, and there are likely to
be multiple contributing factors. Part of the explanation is
likely to be an underestimate of the contribution made by
the types of variants targeted by GWAS. For instance, it
might be that there are large numbers of variants of very
small effect, which early GWAS were underpowered to
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Advance Access published on August 30, 2010Table 1. Established susceptibility loci for RA, T1D, CD and T2D
Chromosome SNP Position Region/gene RAF OR ls Reference
Rheumatoid arthritis
1p36 rs3890745 2553624 TNFSFR14 0.68 1.12 1.003 (16)
1p13 rs2476601 114377568 PTPN22 0.10 1.94 1.068 (16)
1p13 rs11586238 117263138 CD2, CD58 0.24 1.13 1.003 (16)
1q23 rs12746613 161467042 FCGR2A 0.12 1.13 1.002 (16)
1q31 rs10919563 198700442 PTPRC 0.87 1.14 1.002 (16)
2p16 rs13031237 61136129 REL 0.37 1.13 1.004 (16)
2p14 rs934734 65595586 SPRED2 0.49 1.13 1.004 (16)
2q11 rs10865035 100835734 AFF3 0.47 1.12 1.003 (16)
2q32 rs7574865 191964633 STAT4 0.22 1.16 1.004 (16)
2q33 rs1980422 204610396 CD28 0.24 1.12 1.002 (16)
2q33 rs3087243 204738919 CTLA4 0.56 1.15 1.005 (16)
3p14 rs13315591 58556841 PXK 0.09 1.29 1.007 (16)
4p15 rs874040 26108197 RBPJ 0.30 1.14 1.004 (16)
4q27 rs6822844 123509421 IL2, IL21 0.82 1.11 1.002 (16)
5q11 rs6859219 55438580 ANKRD55, IL6ST 0.79 1.28 1.009 (16)
5q21 rs26232 102596720 C5orf13 0.68 1.14 1.004 (16)
6p21 HLA 1.800 (70,71)
6q21 rs548234 106568034 PRDM1 0.33 1.10 1.002 (16)
6q23 rs10499194 138002637 TNFAIP3 0.73 1.10 1.002 (16)
6q23 rs6920220 138006504 TNFAIP3 0.22 1.22 1.008 (16)
6q23 rs5029937 138195151 TNFAIP3 0.04 1.40 1.006 (16)
6q25 rs394581 159482521 TAGAP 0.70 1.10 1.002 (16)
6q27 rs3093023 167534290 CCR6 0.43 1.13 1.004 (16)
7q32 rs10488631 128594183 IRF5 0.11 1.19 1.003 (16)
8p23 rs2736340 11343973 BLK 0.25 1.12 1.003 (16)
9p13 rs2812378 34710260 CCL21 0.34 1.10 1.002 (16)
9q33 rs3761847 123690239 TRAF1, C5 0.43 1.13 1.004 (16)
10p15 rs2104286 6099045 IL2RA 0.73 1.09 1.001 (16)
10p15 rs4750316 6393260 PRKCQ 0.81 1.15 1.003 (16)
11p12 rs540386 36525293 TRAF6 0.86 1.14 1.002 (16)
12q13 rs1678542 57968715 KIF5A 0.62 1.10 1.002 (16)
20q13 rs4810485 44747947 CD40 0.75 1.18 1.005 (16)
22q12 rs3218253 37544810 IL2RB 0.26 1.09 1.001 (16)
Type 1 diabetes
1p31 rs2269241 64108771 PGM1 0.19 1.10 1.001 (15)
1p13 rs2476601 114377568 PTPN22 0.14 2.05 1.104 (15)
1q31 rs2816316 192536813 RGS1 0.82 1.12 1.002 (15)
1q32 rs3024505 206939904 IL10 0.83 1.19 1.004 (15)
2p25 rs1534422 12640741 2p25 0.46 1.08 1.001 (15)
2q12 rs917997 103070568 IL18RAP 0.78 1.20 1.005 (15)
2q24 rs1990760 163124051 IFIH1 0.60 1.16 1.005 (15)
2q33 rs3087243 204738919 CTLA4 0.55 1.14 1.004 (15)
3p21 rs333 46345611 CCR5 0.88 1.18 1.003 (15)
4p15 rs10517086 26085511 4p15 0.30 1.09 1.002 (15)
4q27 rs17388568 123132492 IL2 0.26 1.26 1.011 (15)
5p13 rs6897932 35874575 IL7R 0.73 1.12 1.002 (15)
6p21 MHC 3.058 (72)
6q15 rs11755527 90958231 BACH2 0.47 1.13 1.004 (15)
6q22 rs9388489 126698719 C6orf173 0.45 1.17 1.006 (15)
6q23 rs6920220 137973068 TNFAIP3 0.22 1.09 1.001 (15)
6q25 rs1738074 159465977 TAGAP 0.56 1.09 1.002 (15)
7p15 rs7804356 26891665 7p15 0.76 1.14 1.003 (15)
7p12 rs4948088 51027194 COBL 0.95 1.30 1.002 (15)
9p24 rs7020673 4291747 GLIS3 0.50 1.14 1.004 (15)
10p15 rs11594656 6,62015 IL2RA 0.75 1.19 1.005 (15)
10p15 rs12722495 6137289 IL2RA 0.89 1.59 1.015 (15)
10p15 rs947474 6430456 PRKCQ 0.81 1.10 1.001 (15)
10q23 rs10509540 90023033 C10orf59 0.72 1.33 1.015 (15)
11p15 rs689 2138800 INS 0.71 2.30 1.096 (15)
12p13 rs4763879 9910164 CD69 0.37 1.09 1.002 (15)
12q13 rs2292239 56482180 ERBB3 0.34 1.31 1.018 (15)
12q13 rs1678536 57979190 Multiple 0.72 1.12 1.002 (15)
12q24 rs3184504 111884608 SH2B3 0.49 1.28 1.015 (15)
14q24 rs1465788 69263599 14q24 0.71 1.16 1.004 (15)
14q32 rs4900384 98498951 14q32 0.29 1.09 1.002 (15)
15q25 rs3825932 79235446 CTSH 0.68 1.16 1.005 (15)
Continued
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Chromosome SNP Position Region/gene RAF OR ls Reference
16p13 rs12708716 11179873 CLEC16A 0.65 1.23 1.009 (15)
16p12 rs12444268 20342572 16p12 0.30 1.10 1.002 (15)
16p11 rs4788084 28539848 IL27 0.58 1.16 1.005 (15)
16q23 rs7202877 75247245 16q23 0.10 1.13 1.001 (15)
17p13 rs16956936 7633692 17p13 0.87 1.09 1.001 (15)
17q12 rs2290400 38066240 ORMDL3 0.51 1.15 1.005 (15)
17q21 rs7221109 38770286 17q21 0.65 1.05 1.001 (15)
18p11 rs1893217 12809340 PTPN2 0.17 1.13 1.002 (15)
18q22 rs763361 67531642 CD226 0.47 1.16 1.006 (15)
19q13 rs425105 47208481 19q13 0.84 1.16 1.003 (15)
20p13 rs2281808 1610551 20p13 0.64 1.11 1.002 (15)
21q22 rs11203203 43836186 UBASH3A 0.43 1.13 1.004 (15)
22q12 rs5753037 30581722 22q12 0.39 1.10 1.002 (15)
22q13 rs229541 37591318 C1QTNF6 0.43 1.11 1.003 (15)
Xq28 rs2664170 153945602 Xq28 0.32 1.16 1.005 (15)
Crohn’s disease
1p31 rs11465804 67475114 IL23R 0.93 2.50 1.025 (14)
1p13 rs2476601 114179091 PTPN22 0.90 1.31 1.005 (14)
1q23 rs2274910 159118670 ITLN1 0.68 1.14 1.004 (14)
1q24 rs9286879 171128857 1q24 0.24 1.19 1.006 (14)
1q32 rs11584383 199202489 1q32 0.70 1.18 1.005 (14)
2q27 rs3828309 233845149 ATG16L1 0.53 1.28 1.015 (14)
3p21 rs3197999 49696536 MST1 0.27 1.20 1.007 (14)
5p13 rs4613763 40428485 PTGER4 0.13 1.32 1.010 (14)
5q31 rs2188962 131798704 5q31 0.43 1.25 1.013 (14)
5q33 rs11747270 150239060 IRGM 0.09 1.33 1.008 (14)
5q33 rs10045431 158747111 IL12B 0.71 1.11 1.002 (14)
6p22 rs6908425 20836710 CDKAL1 0.78 1.21 1.006 (14)
6q21 rs7746082 106541962 6q21 0.29 1.17 1.005 (14)
6q27 rs2301436 167357978 CCR6 0.46 1.21 1.009 (14)
7p12 rs1456893 50240218 7p12 0.68 1.20 1.007 (14)
8q24 rs1551398 126609233 8q24 0.62 1.08 1.001 (14)
9p24 rs10758669 4971602 JAK2 0.35 1.12 1.003 (14)
9q32 rs4263839 116606261 TNFSF15 0.68 1.22 1.008 (14)
10p11 rs17582416 35327656 10p11 0.35 1.16 1.005 (14)
10q21 rs10995271 64108492 ZNF365 0.39 1.25 1.012 (14)
10q24 rs11190140 101281583 NKX2-3 0.48 1.20 1.008 (14)
11q13 rs7927894 75978964 C11orf30 0.39 1.16 1.005 (14)
12q12 rs11175593 38888207 LRRK2, MUC19 0.02 1.54 1.005 (14)
13q14 rs3764147 43355925 13q14 0.22 1.25 1.010 (14)
16q12 rs2066847 49321280 NOD2 0.02 3.99 1.147 (14)
17q21 rs2872507 35294289 ORMDL3 0.47 1.12 1.003 (14)
17q21 rs744166 37767727 STAT3 0.57 1.18 1.007 (14)
18p11 rs2542151 12769947 PTPN2 0.15 1.35 1.014 (14)
21q21 rs1736135 15727091 21q21 0.57 1.18 1.007 (14)
21q22 rs762421 44439989 ICOSLG 0.39 1.13 1.004 (14)
Type 2 diabetes
1p13–p11 rs10923931 120319482 NOTCH2 0.11 1.09 1.001 (73)
1q32 rs340874 212225879 PROX1 0.56 1.07 1.001 (18)
2p23 rs780094 27594741 GCKR 0.61 1.06 1.001 (18)
2p21 rs7578597 43586327 THADA 0.90 1.15 1.002 (73)
2p16 rs243021 60438323 BCL11A 0.46 1.08 1.001 (74)
2q26 rs7578326 226728897 IRS1 0.64 1.11 1.002 (74)
3p25 rs1801282 12368125 PPARG 0.85 1.23 1.005 (73)
3p14 rs4607103 64686944 ADAMTS9 0.76 1.10 1.002 (73)
3q13–q21 rs11708067 124548468 ADCY5 0.77 1.12 1.002 (18)
3q27 rs4402960 186994381 IGF2BP2 0.31 1.11 1.002 (73)
4p16 rs10010131 6343816 WFS1 0.59 1.14 1.004 (73)
5q13 rs4457053 76460705 ZBED3 0.26 1.08 1.001 (74)
6p22 rs10946398 20769013 CDKAL1 0.33 1.09 1.002 (73)
7p21 rs2191349 15030834 DGKB/TMEM195 0.47 1.06 1.001 (18)
7p15 rs864745 28147081 JAZF1 0.50 1.08 1.001 (73)
7p15 rs4607517 44202193 GCK 0.2 1.07 1.001 (18)
7q32 rs972283 130117394 KLF14 0.55 1.07 1.001 (74)
8q22 rs896854 96029687 TP53INP1 0.48 1.06 1.001 (74)
8q24 rs13266634 118253964 SLC30A8 0.68 1.12 1.003 (73)
Continued
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vation that meta-analyses of published GWAS are discovering
a substantial number of new susceptibility loci (14–25).
In addition, for most loci, causal variants and potential inde-
pendent additional markers within the region have not been
identiﬁed yet. New ways of analysing the genetic architecture
of complex traits using GWAS data are suggesting that indeed
a large proportion of heritability can be explained by common
variants and that larger GWAS will yield many more validated
loci for complex traits (26,27).
Of course, GWAS only interrogate a portion of the types of
variation that could underlie disease risk. Analysis of GWAS
data has been mainly focused on single nucleotide polymorph-
isms (SNPs), but there are other types of genetic variation,
such as structural variants, that have not been studied in depth.
However, recent studies of common (MAF . 5%) copy
number variants (CNVs) have shown that they seem unlikely
to account for a substantial proportion of the ‘missing heritabil-
ity’ (28). Similarly, the analysis of gene–environment and
gene–gene interactions (epistasis) might improve the fraction
of heritability explained by loci documented thus far. Several
epistatic interactions have been indentiﬁed in humans [e.g.
between the RET protooncogene and endothelin receptor type
B genes in Hirschsprung disease (29), the interleukin 4 receptor
variantsandinterleukin13promotervariantsinasthma(30)and
the alpha- and beta-adrenergic receptors in congestive heart
failure (31)], although they have not been replicated.
However, this phenomenon has not been thoroughly explored
through large-scale analysis of genome-wide SNP interactions,
ﬁrstduetothefactthatcurrentsamplesizesareunderpoweredto
detectmodestinteractioneffectsandsecondlyduetothepaucity
of sample collections with genetic and detailed environmental
exposure data. Complex patterns of inheritance, such as parent
of origin effects (32), as well as inherited epigenetic modiﬁ-
cations of the genome, the presence of phenotype heterogeneity
in the cohorts used in the ﬁrst wave of GWAS, or even an initial
over-estimationoftheheritabilityofcomplextraits(33)canalso
contribute to the missing heritability.
While the above-mentioned plausible contributors seem
unlikely to play a substantial role in explaining missing herit-
ability, rare variants are increasingly thought to account for a
large proportion of it (34–36). Contrary to the CDCV hypoth-
esis, the multiple rare variant (MRV) hypothesis argues that
the summation of the effects of low-frequency polymorph-
isms, each conferring an intermediate increase in risk (i.e.
incompletely penetrant, but greater than those observed for
common variants), can explain a signiﬁcant proportion of
the genetic susceptibility to common diseases and traits.
Some studies analysing rare variants using GWAS data have
been carried out, but these have proven to be underpowered
to detect robust associations. Re-sequencing approaches
are more suitable for rare variant analysis, and, as these are
becoming more cost-effective and new analysis methods are
being developed (37,38), they will soon be applied to
large-scale studies of rare variants. Indeed, several targeted
sequencing studies have already proven successful for the
identiﬁcation of associations between rare variants and some
human diseases and disease-related phenotypes (39–43). The
same argument can also be extended to other forms of
genetic variation, and it has been recently proposed that rare
CNVs may be responsible for some fraction of the missing
heritability of complex traits (44,45).
Table 1. Continued
Chromosome SNP Position Region/gene RAF OR ls Reference
9p21 rs10811661 22124094 CDKN2A/B 0.84 1.17 1.003 (73)
9q21 rs13292136 81141948 CHCHD9 0.93 1.11 1.001 (74)
10p13 rs12779790 12368016 CDC123/CAMK1D 0.18 1.11 1.002 (73)
10q23 rs5015480 94455539 HHEX/IDE 0.59 1.10 1.002 (73)
11p15 rs2334499 1653428 DUSP8 0.41 1.08 1.001 (32)
11p15 rs231362 2648047 KCNQ1 0.52 1.08 1.001 (74)
11p15 rs2237892 2796327 KCNQ1 0.34 1.42 1.031 (73)
11p15 rs5219 17366148 KCNJ11 0.39 1.15 1.005 (73)
11q13 rs1552224 72110746 CENTD2 0.88 1.14 1.002 (74)
11q21 rs10830963 92348358 MTNR1B 0.30 1.09 1.001 (73)
12q14 rs1531343 64461161 HMGA2 0.1 1.1 1.001 (74)
12q14–q21 rs7961581 69949369 TSPAN8/LGR5 0.27 1.06 1.001 (73)
12q24 rs7957197 119945069 HNF1A 0.85 1.07 1.001 (74)
15q25 rs11634397 78219277 ZFAND6 0.6 1.06 1.001 (74)
15q26 rs8042680 89322341 PRC1 0.22 1.07 1.001 (74)
16q12 rs8050136 52373776 FTO 0.38 1.21 1.009 (73)
17cen–q21.3 rs757210 33170628 HNF1B (TCF2) 0.38 1.10 1.002 (73)
Xq28 rs5945326 152553116 DUSP9 0.21 1.27 1.011 (74)
RA, rheumatoid arthritis; T1D, type 1 diabetes; CD, Crohn’s disease; T2D, type 2 diabetes; RAF, risk allele frequency in controls; OR, odds ratio.
Sibling recurrence risk ratio (ls) was calculated using the formula:
ls = 1 +
pq(g − 1)2
2(p + gq)2
 2
where q is the risk allele frequency, p ¼ 1 2 q, and g is the genotype relative risk under the additive model.
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It has been recently proposed that GWAS signals that have
been credited to common variants could instead reﬂect the
effect of MRVs. Dickson et al.( 46) argue that rare variants
can create ‘synthetic association’ signals in GWAS, by occur-
ring more often in association with one of the alleles of a
common tag SNP (Fig. 1), which would thus synthetically
confer an increased risk for disease. This might also mean
that the causal variants could be megabases away from the
common variants detected in GWAS, and that the real effect
size could be much stronger than that implied by the
common tag SNP. If true, the synthetic association hypothesis
would suggest that follow-up studies from GWAS hits should
encompass a much larger region than the linkage disequili-
brium region surrounding the detected common variant (6).
There are very few documented examples showing that
MRVs may be responsible for a common variant GWAS
signal (47). It therefore seems sensible to evaluate this hypo-
thesis in the broader context of human disease genetics,
including historical study designs, functional annotations of
GWAS regions and experiments in human populations with
diverse ancestry. While sequencing experiments currently
underway or in planning will ultimately resolve the role of
synthetic association, the balance of evidence available
today is already illuminating.
LINKAGE EVIDENCE SUGGESTS SYNTHETIC
ASSOCIATIONS ARE RARE
One line of evidence that suggests that synthetic associations
do not underlie many reported GWAS associations is provided
by linkage scans that have been conducted in the past. The
genetic model that underpins synthetic association (allelic
heterogeneity caused by several low-frequency variants with
larger effects than commonly seen in GWAS) is highly tract-
able by linkage analysis, which combines information from all
causal variants at a particular locus. This relationship is high-
lighted by the widely replicated linkage between the NOD2
gene and CD, which is driven by three independent, low-
frequency causal variants (48–50) which cause a synthetic
association signal in GWAS of CD (Fig. 1). NOD2 is the
exception that proves the rule that, despite many attempts,
very few replicable linkages to complex diseases have been
discovered (51). This dearth of ﬁndings is informative when
considering the likelihood of synthetic associations because
it rules out a class of genetic models from playing a substantial
role in complex disease.
Power calculations comparing a large-scale linkage scan
(52) with the largest GWAS considered by Dickson et al.
(46) show that only a small fraction of the genetic models
which can give rise to synthetic associations would not be
detected by linkage. Furthermore, the scenario where synthetic
associations could have escaped linkage comprises models
with a small number of causal variants with genotype relative
risk ,2.5 (53). While these observations do not entirely rule
out synthetic associations, they seriously conﬁne the parameter
space in which they might exist. In addition, comparisons of
even modest linkage signals with GWAS regions have
shown only a few overlaps, and even these are largely
driven by atypically large effects like the MHC in autoimmu-
nity. In addition, attempts to explicitly use linkage information
to boost the power of GWAS (54) have not been successful.
This contrast between largely overlapping genetic models
that linkage and synthetic association are well powered to
detect and almost completely non-overlapping results from
linkage and GWAS strongly suggests that synthetic associ-
ations do not underlie many GWAS signals.
PATHWAY ANALYSES IMPLY GWAS ARE
POINTING TO KEY FUNCTIONAL ELEMENTS
Another prediction made by the synthetic association hypo-
thesis is that the most signiﬁcantly associated common
variant identiﬁed by GWAS might be located several mega-
bases away from the underlying low-frequency functional var-
iants. The empirical properties of linkage disequilibrium
between low-frequency and common variants are not fully
understood, although the complete 1000 Genomes project
(http://www.1000genomes.org/) will soon provide information
necessary to evaluate this question directly. Nevertheless, two
indirect pieces of evidence suggest that most GWAS hit SNPs
are within a few hundred kilobases (and many within tens of
kilobases) of their tagged functional alleles. First, a large
number of GWAS signals across a variety of traits are
nearby to genes previously established to cause Mendelian
forms of the same trait (55). Secondly, genes involved in
key pathways repeatedly arise in GWAS of some diseases.
For example, 8 of 10 proteins involved in the
Th17-differentiation signalling pathway have been associated
with one or more auto-inﬂammatory diseases (56). As with
many aspects relating to the evaluation of the prevalence of
synthetic associations, deeper sequence data sets will be
needed to fully answer the question of the distance between
GWAS tag SNPs and causal variants, but these early patterns
imply that the tag SNP often resides in the proximity of the
relevant functional genomic element.
TRANS-ETHNIC ASSOCIATIONS ARE
WIDESPREAD
Under the synthetic associations model, common variant
signals reﬂecting single or multiple rare alleles are unlikely
to be consistent across populations of different ancestry.
This is based on the fact that many of these rare variants
would have arisen recently and will therefore not be shared
across diverged populations. The majority of GWAS to date
have focused on populations of European descent. However,
data on more diverse populations are now starting to arise.
For example, a study from early 2010 clearly demonstrated
that common variant signals for T2D are reproducible and
have similar effect sizes across East Asian populations includ-
ing Chinese, Malays and Asian-Indians in Singapore (57). In
fact, T2D-associated variants have been found to be associated
with disease in diverse populations (ranging from
African-Americans to Chinese) by several studies (58–62).
Similarly, in RA, the STAT4 locus, as an example, has
shown reproducible association with disease in the USA
Human Molecular Genetics, 2010, Vol. 19, Review Issue 2 R141(63), UK (64), Spanish, Swedish, Dutch (65), Korean (66),
Colombian (67), Japanese (68) and Greek (69) populations.
FUTURE DIRECTIONS FOR GWAS AND THE
SEARCH FOR GENETIC CAUSES OF COMMON
DISEASE
Although synthetic associations explaining common GWAS
signals for complex polygenic traits are certainly plausible
and can occur under speciﬁc circumstances (e.g. NOD2 in
CD), results from studies thus far suggest that these scenarios
are actually a rarity. The idea that MRVs at a particular locus
may be associated with complex traits of interest has been
around for over a decade. We are now starting to accrue a
growing body of empirical evidence in support of this hypoth-
esis. The ﬁeld of complex trait genetics has over the last few
months engaged in discussions on the controversial topic of
synthetic associations, but it transpires that there is little evi-
dence to support this as a widespread scenario.
Empowered by advances in sequencing technologies, atten-
tion is currently shifting towards the comprehensive study of
low-frequency and rare variants. Resources such as the 1000
genomes project and emerging large-scale studies like the
UK10k project will undoubtedly facilitate the examination
of variants at this end of the allele frequency spectrum. In par-
allel, improved strategies for accurate imputation and power-
ful analysis of low-frequency and rare variants in aggregate
are being further developed and ﬁne-tuned to the needs of
these next generation truly genome-wide scans for association.
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